Literature DB >> 14587415

[Two cases of radiation myositis probably induced by recall phenomenon].

Gouji Miura1, Tsuneo Matsumoto, Nobuyuki Tanaka, Takuya Emoto, Takeo Kawamura, Naofumi Matsunaga.   

Abstract

Two cases of radiation myositis following gemcitabine-based chemotherapy for advanced non-small cell lung cancer are presented. In the two cases, myositis appeared 3 and 5.5 months after the completion of radiation therapy and 2 and 2.5 months after the beginning of chemotherapy, respectively. The affected areas, the upper back and right thigh, appeared as areas of increased signal intensity on T2-weighted MR imaging and were enhanced by the administration of Gd-DTPA in the skeletal muscles. These coincided with the previously irradiated area. Although radiation myositis is a rare complication, it is important to be careful of radiation recall induced by chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14587415

Source DB:  PubMed          Journal:  Nihon Igaku Hoshasen Gakkai Zasshi        ISSN: 0048-0428


  3 in total

1.  Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.

Authors:  Elena Pentsova; Anli Liu; Marc Rosenblum; Eileen O'Reilly; Xi Chen; Adília Hormigo
Journal:  J Neurooncol       Date:  2011-08-03       Impact factor: 4.130

Review 2.  Radiation recall with anticancer agents.

Authors:  Howard A Burris; Jane Hurtig
Journal:  Oncologist       Date:  2010-11-02

3.  Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature.

Authors:  Adarsh Ravishankar; Sean S Park; Kenneth R Olivier; Kimberly S Corbin
Journal:  Case Rep Oncol       Date:  2018-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.